EP3422874A1 - Vibrationsvertropfung - Google Patents

Vibrationsvertropfung

Info

Publication number
EP3422874A1
EP3422874A1 EP17707050.5A EP17707050A EP3422874A1 EP 3422874 A1 EP3422874 A1 EP 3422874A1 EP 17707050 A EP17707050 A EP 17707050A EP 3422874 A1 EP3422874 A1 EP 3422874A1
Authority
EP
European Patent Office
Prior art keywords
modified
oil
dispersion
particles
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17707050.5A
Other languages
German (de)
English (en)
French (fr)
Inventor
Kathrin Meyer-Boehm
Thrandur HELGASON
Karl Kolter
Walter Dobler
Christof STADAGER
Michael Schoenherr
Katja KESTEN
Nikolaus Nestle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of EP3422874A1 publication Critical patent/EP3422874A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Definitions

  • the present invention relates to a method for the production of carotenoid and / or vitamin and / or omega-3 fatty acids and / or phytosterols and / or conjugated linoleic acid-containing particles with narrow particle size distribution and uniform spherical shape and density, as well as particles obtainable by this method and their use as dietary supplements, food, feed, personal care product and medicines.
  • the particles according to the invention have an improved storage stability compared with the prior art.
  • the carotenoid and / or vitamin-containing particles produced according to the process described in US Pat. No. 4,522,743 have a high proportion of air inclusions, which can amount to> 40% of the void volume based on the total volume of the particles. These air pockets make the particles less mechanically stable than massive particles. The particles can be damaged during further processing and thus deteriorate the product properties. In addition to the air inclusions, these particles are usually characterized by a broad particle size distribution, possibly paired with a rather uneven particle shape.
  • these preparations due to breakage of the hollow spheres under mechanical stress, but also due to the broad particle size distribution and the associated fine dust content and the uneven particle shape, these preparations have a large surface area, which makes them sensitive to oxidative attack of oxygen on the carotenoids and vitamins contained in the particles.
  • the object of the invention is therefore to provide a method which provides particles which do not possess these disadvantages of the prior art.
  • the object is achieved by methods in which to produce spherical particles by dispersing carotenoid and / or vitamin and / or omega-3 fatty acids and / or phytosterols and / or conjugated linoleic acids in a hydrocolloid-containing solution and the dispersion formed by a Dropped Vibration dropping method and the resulting drops solidified by evaporation of the solvent and dried.
  • Spherical in the sense of the invention means that the individual particles each have an aspect ratio of 1 to 1, 2. "Aspect Ratio" is the quotient of the largest and the smallest particle diameter.
  • dispersion in the context of the present invention both emulsions and suspensions.
  • the nozzle and / or the dispersion and / or a reservoir receiving the dispersion and / or a feed line feeding the dispersion of the nozzle are excited to vibrate.
  • vibration exciter a me- mechanical oscillator, magnetic oscillator, pneumatic vibrator, piezoelectric transducer or electro-acoustic transducer.
  • the vibration exciter can act on the nozzle and / or supply line and / or on the reservoir. It is also possible to directly sonicate the dispersion, for example with an electroacoustic transducer, or to excite it directly with a vibrating displacer / plunger in order to drop the dispersion emerging from the nozzle into uniform drops.
  • the frequency which acts on the device or the dispersion is to be kept constant during the production process, wherein preferably excitation frequencies between 50 and 10000 Hz, preferably in the range 100 to 5000 Hz and particularly preferably in the range 400-4000 Hz are used.
  • the viscosity of the dispersions is> 80 mPas at 40 ° C.
  • the diameter of the nozzle should eventually be in the range between 50 and 1000 ⁇ .
  • spherical particles can be produced with a narrow particle size distribution, with particles having a diameter between 100 and 1500 ⁇ m being achievable as a function of the frequency and the nozzle diameter.
  • the process is preferably carried out in such a way that spherical particles with a particle size distribution of> 75% in the range of 150 to ⁇ , preferably> 85% in the range of 150 to 600 ⁇ and particularly preferably> 95% of 150 to 600 ⁇ are obtained.
  • the process is characterized in that the polydispersity, measured as the range of the particle size distribution (X90-X10 divided by X50), is less than 1.0, preferably less than 0.8 and more preferably less than 0.6, the X50 value being the mean Particle size distribution and the difference X90-X10 represents the width of the particle size distribution.
  • the content of the spherical particles consists of a hydrocolloid matrix in which homogeneously distributed carotenoid (s) and / or vitamin (s) and / or omega-3 fatty acids and / or phytosterols and / or conjugated linoleic acids are present. These particles are distinguished by the fact that the void volume trapped in the particles is ⁇ 40%, preferably ⁇ 30% and particularly preferably ⁇ 20% of the total volume of the particles.
  • carotenoids and / or vitamins and / or omega-3 fatty acids and / or phytosterols and / or conjugated linoleic acids are vitamins A, D, E or K or their derivatives, for example vitamin A and vitamin E Esters such as retinyl acetate or tocopherol acetate, tocotrienol, vitamin K1, vitamin K2, and also carotenoids, such as Carotene, canthaxanthin, astaxanthin, citranaxanthin and ester derivatives, zeaxanthin and ester derivatives, lutein and ester derivatives, lycopene and apocarotenal.
  • vitamins A, D, E or K or their derivatives for example vitamin A and vitamin E Esters such as retinyl acetate or tocopherol acetate, tocotrienol, vitamin K1, vitamin K2, and also carotenoids, such as Carotene, canthaxanthin, astaxanthin, citranaxanthin and ester
  • Suitable hydrocolloids are according to the invention plant gums, modified plant gums, gelatin, modified gelatin, modified starch, lignosulfonate, chitosan, carrageenan, casein, caseinate, whey protein, zein, modified cellulose, pectin, modified pectin, vegetable proteins and modified vegetable proteins or mixtures thereof.
  • the plant gums include agar, alginic acid, alginate, chicle, dammar, marshmallow extracts, gellan, guar gum, gum arabic, gum from plantar core, gum from spruce juice, locust bean gum, karaya, konjac flour, mastic, tara gum, tragacanth, xanthane.
  • hydrocolloid is gelatin and / or plant gums and / or modified plant gums and, in particular, gum arabic among the plant gums.
  • an antioxidant can be added to the hydrocolloid solution before or after addition of the carotenoid and / or vitamin and / or omega-3 fatty acids and / or phytosterols and / or conjugated linoleic acids to increase the stability of these against oxidative degradation.
  • the antioxidant is selected from the group consisting of dl-a-tocopherol, tocopherol, ß-tocopherol, ⁇ -tocopherol, ⁇ -tocopherol, butylhydroxytoluene (BHT), butylhydroxyanisole, propyl gallate, octyl gallate, dodecyl gallate, extracts of rosemary , Extracts of green tea and other gallic acid derivatives, tert-butylhydroxyquinoline, ethoxyquin, carnosol, carnosic acid, ascorbyl palmitate and ascorbyl stearate or mixtures thereof.
  • BHT butylhydroxytoluene
  • the proportion of antioxidants in the particle composition is 0.1 to 10 wt .-%, preferably 0.5 to 8.5 wt .-%, based on the dry matter of the carotenoid and / or vitamin and / or omega-3 fatty acids and / or phytosterols and / or conjugated linoleic acid-containing particle composition (without powdering agent), the sum of the percentages of the individual components being 100%.
  • a plasticizer such as sucrose, glucose, glucose syrup, lactose, invert sugar and other glucose fructose compositions, sorbitol, mannitol, glycerol, maltodextrins, isomaltose or isomalt.
  • the designation voltage isomalt is a sugar substitute that also under the brand name Palatinit ® (Fa. Südzucker, Germany) is performed.
  • Isomalt is a hydrogenated isomaltulose consisting of approximately equal parts of 6-OaD-glucopyranosyl-D-sorbitol and 1 -OaD-glucopyranosyl-D-mannitol.
  • plasticizers are sucrose, glucose syrup, sorbitol and lactose.
  • the ratio of protective colloid and plasticizer to carotenoid and / or vitamin and / or omega-3 fatty acids and / or phytosterols and / or conjugated linoleic acids is generally chosen so as to obtain a solid preparation containing between 0.01 and 50 wt .-% Ca contains redoid and / or vitamin, 10 to 65 wt .-%, preferably 15 to 60 wt .-% of a protective colloid and 5 to 60 wt .-%, preferably 10 to 50 wt .-% of a plasticizer, all percentages on refer to the dry matter of the particle composition (without powdering agent) and the sum of the percentages of the individual components is 100%.
  • emulsifiers for example, ascorbyl palmitate, polyglycerol fatty acid esters, sorbitan fatty acid esters, propylene glycol fatty acid esters or lecithin in a concentration of 0 to 200 wt .-%, preferably 5 to 150 wt .-%, particularly preferably 10 to 80 wt .-%, based on the used carotenoids and / or vitamins.
  • a physiologically approved oil such as sesame oil, corn oil, cottonseed oil, soybean oil, peanut oil, sunflower oil, rapeseed oil, coconut oil, palm oil, olive oil, animal fats, lard, tallow, modified oils or mixtures thereof in one concentration from 0 to 500 wt.%, Preferably 10 to 300 wt.%, Particularly preferably 20 to 100 wt.%, Based on the / the carotenoids and / or vitamins to use.
  • a physiologically approved oil such as sesame oil, corn oil, cottonseed oil, soybean oil, peanut oil, sunflower oil, rapeseed oil, coconut oil, palm oil, olive oil, animal fats, lard, tallow, modified oils or mixtures thereof in one concentration from 0 to 500 wt.%, Preferably 10 to 300 wt.%, Particularly preferably 20 to 100 wt.%, Based on the / the carotenoids and / or vitamins to use.
  • auxiliary agents and additives which are customary for the production of carotenoid and / or omega-3 fatty acids and / or phytosterols and / or conjugated linoleic acid particle compositions, such as e.g. inorganic and organic salts are added.
  • the proportion of auxiliaries and additives is generally from 0.2 to 20 wt .-%, preferably 0.3 to 15 wt .-%, particularly preferably 0.4 to 10 wt .-%, most preferably 0.5 to 5% by weight, based on the dry mass of the particle composition (without powdering agent), the sum of the percentages of the individual components being 100%.
  • a powdered preparation can be prepared in a manner known per se, e.g. according to the specifications of DE2534091 by spray drying or by spray cooling or by enveloping the particles, separating and drying in a fluidized bed.
  • the droplets formed are thereby enveloped by a powdering agent which can be selected from hydrophobic silica, hydrophilic silica, starch, modified starch, corn starch, celluloses, modified celluloses, calcium silicate, calcium magnesium silicate, calcium carbonate, tricalcium phosphate, calcium adipate, magnesium adipate, titanium dioxide, lignins , fumed pectin, modified pectin, plant proteins, modified plant proteins, and combinations thereof.
  • the inventive method is characterized in that the drops produced are coated with a powder at temperatures between 10 and 80 ° C and then solidified at inlet temperatures between 40 and 120 ° C and dried. Preference is given to a process procedure in which a dispersion containing carotenoid and / or omega-3 fatty acids and / or phytosterols and / or conjugated linoleic acids is sprayed into an inert gas atmosphere laden with the impregnating agents hydrophobic silica or cornstarch.
  • a process procedure is preferred in which after spraying to a residual moisture content below 10% by weight, preferably below 6% by weight is dried.
  • the invention also relates to particle compositions which contain, in addition to the constituents mentioned, 0.025 to 4 times by weight the active ingredient in powder or powder mixtures.
  • the use of the preparation forms according to the invention as a dietary supplement, food, feed, personal care product and medicaments is claimed. pictures:
  • FIG. 1 Scanning electron micrograph of the particles produced according to FIG. 1A.
  • FIG. 2 Scanning electron micrograph of the particles produced according to FIG. 1B
  • the molecular-disperse solution in mixing chamber B is mixed with a solution of 32 g of gelatin and 120 g of glucose syrup in 4000 g of water at a rate of 100 l / h of isopropanol.
  • a drug dispersion is obtained, which can be converted by spray drying in a stable, water-soluble dry powder. After dissolution in water, a particle size of 150 nm is measured.
  • the emulsion thus prepared was sprayed through a nozzle at 25 bar into a spray tower in which hydrophobic silica was fluidized at 60.degree.
  • the still moist particles were after-dried for 5 h at 60 ° C air inlet temperature in the underlying fluidized bed.
  • a broad particle size Distribution ( Figure 3) with a maximum at about 500 ⁇ associated with a high void fraction based on the total volume of the particles determined.
  • Example 1A Determination of the hollow sphere portion of Example 1A In a 15 ml centrifuge tube 4 ml of the prepared particles were placed. Subsequently, n-pentane was added to the tube until a volume of 12 ml was reached. The tube was sealed and shaken until the particles whirled completely off the bottom. The tube was then placed upright and the measurement was evaluated after 5 minutes.
  • the hollow sphere quantity was read off at a mm scale and indicated in millimeter steps.
  • Example 1A an average of 6.2mm was measured in triplicate.
  • Example 1 B was carried out analogously to Example 1A with the difference that a
  • Vibrating nozzle with a pressure of 0.5bar was used.
  • the device used was a Buchi Encapsulator B-390 with a 200 ⁇ nozzle opening at a frequency of 1400Hz.
  • the flow rate for a nozzle was 30g per hour.
  • a narrow particle size distribution (FIG. 3) was determined with a maximum at about 400 ⁇ m, combined with a very low void fraction based on the total volume of the particles.
  • Example 1B According to the experimental procedure of Example 1A, the hollow sphere amount of Example 1B was determined.
  • Example 1B an average of 0mm was measured in triplicate.
  • test samples of 25 mg each of the prepared particles and 4 g premix mixture were weighed into 50 ml glass bottles.
  • the premix mixture consisted of 20% wheat bran, 20% 50% silica supported choline chloride and 10% trace element mixture.
  • the trace element mixture consisted of 46.78% FeS0 4 x7H 2 0, 37.43% CuS0 4 x5H 2 0, 1 1, 79% ZnO, 3.61% MnO and 0.39% COCO 3.
  • the test samples were carefully mixed by hand. These test samples were stored in a climatic chamber at 40 ° C and 70% for 4 weeks. Before the storage and after the storage was completed, the Canthaxanthin content of the test samples determined. Retention was calculated from the ratio of canthaxanthin levels before and before storage.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Formation And Processing Of Food Products (AREA)
EP17707050.5A 2016-03-02 2017-02-28 Vibrationsvertropfung Withdrawn EP3422874A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16158251 2016-03-02
PCT/EP2017/054586 WO2017148907A1 (de) 2016-03-02 2017-02-28 Vibrationsvertropfung

Publications (1)

Publication Number Publication Date
EP3422874A1 true EP3422874A1 (de) 2019-01-09

Family

ID=55484854

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17707050.5A Withdrawn EP3422874A1 (de) 2016-03-02 2017-02-28 Vibrationsvertropfung

Country Status (5)

Country Link
US (1) US20190090529A1 (zh)
EP (1) EP3422874A1 (zh)
JP (1) JP2019516345A (zh)
CN (1) CN108697149A (zh)
WO (1) WO2017148907A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019000846A (es) 2016-07-19 2019-06-24 Basf Se Preparaciones de vitaminas que contienen galato de propilo.
WO2018108639A1 (en) 2016-12-13 2018-06-21 Basf Se Filaments for use as a support material in fused deposition modeling
KR20210023890A (ko) 2018-06-27 2021-03-04 바스프 에스이 더스트-프리 냉수-분산성 제제
AU2020365042A1 (en) * 2019-10-11 2022-04-07 Dsm Ip Assets B.V. New feed additives of carotenoids
CN111838675A (zh) * 2020-08-25 2020-10-30 无限极（中国）有限公司 一种制备油脂微球粉体的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
DE3119383A1 (de) 1981-05-15 1982-12-02 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten
DE19651681A1 (de) * 1996-12-12 1998-06-18 Basf Ag Stabile, wäßrige Dispersionen und stabile, wasserdispergierbare Trockenpulver von Xanthopyllen, deren Herstellung und Verwendung
ATE262976T1 (de) * 1998-03-07 2004-04-15 Inotech Ag Verfahren und vorrichtung zum verkapseln von mikrobiellen, pflanzlichen und tierischen zellen bzw. von biologischen und chemischen substanzen
US6328995B1 (en) * 1999-09-24 2001-12-11 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form and process for their production
DE10158046A1 (de) * 2001-11-27 2003-06-05 Basf Ag Formulierung für den Einsatz in Lebensmitteln, Nahrungsergänzungsmitteln, Futtermitteln, Futterzusatzstoffen, pharmazeutischen und kosmetischen Zubereitungen sowie Verfahren zu deren Herstellung
EP1413298B1 (de) * 2002-09-24 2007-11-21 Cognis IP Management GmbH Verfahren zur Herstellung von Makrokapseln
ATE402758T1 (de) * 2004-02-06 2008-08-15 Basf Se Wässrige dispersion und ihre verwendung
DE102005030952A1 (de) * 2005-06-30 2007-01-18 Basf Ag Verfahren zur Herstellung einer wässrigen Suspension und einer pulverförmigen Zubereitung eines oder mehrerer Carotinoide
EP1964479B1 (en) * 2007-02-14 2013-05-15 DSM IP Assets B.V. Process for the manufacture of a powder containing carotenoids
US9445997B2 (en) * 2007-12-21 2016-09-20 Basf Se Microcapsules comprising a fat-soluble active substance
CN101480609B (zh) * 2009-01-21 2010-08-11 上海三瑞高分子材料有限公司 一种合成生物柴油的核壳结构纳米固体碱催化剂制备方法
US20130251855A1 (en) * 2012-03-21 2013-09-26 Pepsico, Inc. Aqueous product comprising oil-containing microcapsules and method for the manufacture thereof
EP2925880B1 (en) * 2012-11-27 2020-07-01 DSM IP Assets B.V. Process for the production of discrete solid extruded particles
GB201509606D0 (en) * 2015-06-03 2015-07-15 Anabio Technologies Ltd Microencapsulates containing stabilised marine-derived oil, and methods for production thereof

Also Published As

Publication number Publication date
US20190090529A1 (en) 2019-03-28
WO2017148907A1 (de) 2017-09-08
CN108697149A (zh) 2018-10-23
JP2019516345A (ja) 2019-06-20

Similar Documents

Publication Publication Date Title
EP3422874A1 (de) Vibrationsvertropfung
EP0551638B1 (de) Stabile, flüssige Präparate fettlöslicher Substanzen
EP1575378A1 (de) Pulverförmige phytosterol-formulierungen
US9675557B2 (en) Process for the production of discrete solid extruded particles
EP0835613B1 (de) Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung
EP0986963A2 (de) Stabile, pulverförmige Lycopin-Formulierungen, enthaltend Lycopin mit einem Kristallinitätsgrad von grösser 20%
DE19838636A1 (de) Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein
EP1088486B1 (de) Stabile pulverförmige Vitamin-und/oder Carotinoid-Präparate und Verfahren zu deren Herstellung
DE19637517A1 (de) Herstellung von pulverförmigen, kaltwasserdispergierbaren Carotinoid-Zubereitungen und die Verwendung der neuen Carotinoid-Zubereitungen
WO2000066665A1 (de) Stabile, wassrige dispersionen und stabile, wasserdispergierbare trockenpulver von xanthophyllen, deren herstellung und verwendung
US9833409B2 (en) Process for the production of discrete solid extruded particles
EP2403362B1 (de) Pulverförmige zusammensetzungen von astaxanthin-derivaten ii
EP1186292B1 (de) Carotinoidtrockenpulver mit einer Multi-Kern Struktur
EP3432730B1 (de) Mehrphasige wirkstoffzubereitungen
EP0276772A2 (de) Verfahren zur Herstellung von mikrodispersen Fischölpräparaten
WO2004012707A1 (de) Suspensionen von salzen der ascorbinsäure und ihre verwendung als antioxidantien
DE69906989T2 (de) Gelatinöse zusammensatzug aus fisch zur verwendung als bestandteil von tabletten
WO2005023011A2 (de) Formulierung auf phospholipidbasis
EP3487319A1 (de) Propylgallathaltige vitaminzubereitungen
CA2274516C (en) Process for the preparation of emulsified powders
WO2020001906A1 (de) Staubfreie kalt wasserdispergierbare zubereitungen
WO2022165006A1 (en) Stable emulsions and methods
EP1095986A1 (de) Verfahren zur Stabilisierung von flüssigen, wässrigen Präparaten fettlöslicher Substanzen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181002

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20201124

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230901